AKT1 and hepatocellular carcinoma: In this study, we report for the first time about the positive antitumor effect of haprolid, a novel natural polyketide–peptide hybrid, in HCC models, both in vitro and in vivo through dual inhibition of Rb/E2F and Akt/mTOR pathways.